^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Neuroendocrine Tumor |
| Regimen: | FAS |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Pancreatic Neuroendocrine Tumors (Well-Differentiated Grade 1/2): Other Recommended Regimens...Cytotoxic chemotherapy options considered in patients with bulky, symptomatic, and/or progressive disease include: 5-FU + doxorubicin + streptozocin (FAS).